Wakefulness-Promoting Agents

DBCAT001105Therapeutic category

A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. A DrugBank category of 5 drugs. 5 of them are approved.

Also known as: Agents, Wake-Promoting · Agents, Wakefulness-Promoting · Drugs, Eugeroic · Drugs, Wake-Promoting · Eugeroic Drugs
Drugs: Armodafinil
Daridorexant
Modafinil
Oveporexton
Solriamfetol

What you can answer from here — as of August 24, 2016

5DrugsEach linked to its full drug card

Listed above

6Drug targetsEvery drug–target pair in the class, with bond type

286Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Wakefulness-Promoting Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account